Synthesis and Structure–Activity Relationship Studies of Quinoxaline Derivatives as Aldose Reductase Inhibitors
Quinoxaline
Aldehyde Reductase
IC50
DOI:
10.1002/cmdc.201300324
Publication Date:
2013-10-04T09:52:10Z
AUTHORS (7)
ABSTRACT
ARIs for diabetes: A series of 2-(3-benzyl-2-oxoquinoxalin-1(2H)-yl)acetic acid derivatives were designed and synthesized as inhibitors aldose reductase (AR), a novel target the treatment diabetes complications. Most proved to be potent selective, with IC50 values in low nanomolar micromolar range.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (33)
CITATIONS (67)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....